Intravitreal Bevacizumab vs Sub-Tenon Triamcinolone Acetonide for Choroidal Neovascularization Attributable to Pathologic Myopia

American Journal of Ophthalmology

Volumn 148, Issue 4, 2009, Pages

  Wakabayashi, Taku ^a   Ikuno, Yasushi ^a   Gomi, Fumi ^a   Hamasaki, Toshimitsu ^a   Tano, Yasuo ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGLAUCOMA AGENT; BEVACIZUMAB; TRIAMCINOLONE; TRIAMCINOLONE ACETONIDE;

ABSENCE OF SIDE EFFECTS; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; FEMALE; HUMAN; INTRAOCULAR HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MYOPIA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REFRACTION ERROR; SUBRETINAL NEOVASCULARIZATION; TREATMENT RESPONSE; VISUAL ACUITY;

EID: 70349272176     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2009.05.026     Document Type: Article

References (32)

1. Soubrane G., and Coscas G.J. Choroidal neovascular membrane in degenerative myopia. In: Ryan S.J. (Ed). Retina, 4th ed (2005), Mosby, St Louis, Missouri 1136-1152
2. Avila M.P., Weiter J.J., Jalkh A.E., Trempe C.L., Pruett R.C., and Schepens C.L. Natural history of choroidal neovascularization in degenerative myopia. Ophthalmology 91 (1984) 1573-1581
3. Yoshida T., Ohno-Matsui K., Yasuzumi K., et al. Myopic choroidal neovascularization: a 10-year follow-up. Ophthalmology 110 (2003) 1297-1305
4. VIP Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial-VIP Report No. 3. Ophthalmology 110 (2003) 667-673
5. Axer-Siegel R., Ehrlich R., Yassur Y., et al. Photodynamic therapy for age-related macular degeneration in a clinical setting: visual results and angiographic patterns. Am J Ophthalmol 137 (2004) 258-264
6. Lam D.S., Chan W.M., Liu D.T., Fan D.S., Lai W.W., and Chong K.K. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization of pathologic myopia in Chinese eyes: a prospective series of 1- and 2-year follow-up. Br J Ophthalmol 88 (2004) 1315-1319
7. Krebs I., Binder S., Stolba U., Glittenberg C., Brannath W., and Goll A. Choroidal neovascularization in pathologic myopia: 3-year results after photodynamic therapy. Am J Ophthalmol 140 (2005) 416-425
8. Hayashi K., Ohno-Matui K., Teramukai S., et al. Photodynamic therapy with verteporfin for choroidal neovascularization of pathologic myopia in Japanese patients: comparison with nontreated controls. Am J Ophthalmol 145 (2008) 518-526
9. Michels S., and Schmidt-Erfurth U. Sequence of early vascular events after photodynamic therapy. Invest Ophthalmol Vis Sci 44 (2003) 2147-2154
10. Ohno-Matsui K., Moriyama M., Hayashi K., and Mochizuki M. Choroidal vein and artery occlusion following photodynamic therapy in eyes with pathologic myopia. Graefes Arch Clin Exp Ophthalmol 244 (2006) 1363-1366
11. Matsuda S., Gomi F., Oshima Y., Tohyama M., and Tano Y. Vascular endothelial growth factor reduced and connective tissue growth factor induced by triamcinolone in ARPE19 cells under oxidative stress. Invest Ophthalmol Vis Sci 46 (2005) 1062-1068
12. Potter M.J., Szabo S.M., and Ho T. Combined photodynamic therapy and intravitreal triamcinolone for the treatment of myopic choroidal neovascularization in a 13-year-old girl. Graefes Arch Clin Exp Ophthalmol 244 (2006) 639-641
13. Marticorena J., Gomez-Ulla F., Fernandez M., Pazos B., Rodriguez-Cid M.J., and Sanchez-Salorio M. Combined photodynamic therapy and intravitreal triamcinolone acetonide for the treatment of myopic subfoveal choroidal neovascularization. Am J Ophthalmol 142 (2006) 335-337
14. Chan W.M., Lai T.Y., Wong A.L., Liu D.T., and Lam D.S. Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study. Br J Ophthalmol 91 (2007) 174-179
15. Kojima A., Ohno-Matsui K., Futagami S., Shimada N., Tokoro T., and Mochizuki M. Trans-Tenon's retrobulbar triamcinolone infusion for myopic choroidal neovascularization. Acta Ophthalmol Scand 84 (2006) 749-754
16. Sakaguchi H., Ikuno Y., Gomi F., et al. Intravitreal injection of bevacizumab for choroidal neovascularisation associated with pathological myopia. Br J Ophthalmol 91 (2007) 161-165
17. Yamamoto I., Rogers A.H., Reichel E., Yates P.A., and Duker J.S. Intravitreal bevacizumab (Avastin) as treatment for subfoveal choroidal neovascularisation secondary to pathological myopia. Br J Ophthalmol 91 (2007) 157-160
18. Chan W.M., Lai T.Y., Liu D.T., and Lam D.S. Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularization: 6-month results of a prospective pilot study. Ophthalmology 114 (2007) 2190-2196
19. Hernández-Rojas M.L., Quiroz-Mercado H., Dalma-Weiszhausz J., et al. Short-term effects of intravitreal bevacizumab for subfoveal choroidal neovascularization in pathologic myopia. Retina 27 (2007) 707-712
20. Arias L., Planas N., Prades S., et al. Intravitreal bevacizumab (Avastin) for choroidal neovascularisation secondary to pathological myopia: 6-month results. Br J Ophthalmol 92 (2008) 1035-1039
21. Chang L.K., Spaide R.F., Brue C., Freund K.B., Klancnik Jr. J.M., and Slakter J.S. Bevacizumab treatment for subfoveal choroidal neovascularization from causes other than age-related macular degeneration. Arch Ophthalmol 126 (2008) 941-945
22. Ikuno Y., Sayanagi K., Soga K., et al. Intravitreal bevacizumab for choroidal neovascularization due to pathological myopia-1-year results. Am J Ophthalmol 147 (2009) 94-100
23. Akaike H. Information theory and an extension of the maximum likelihood principle. In: Petrov B.N., and Csaki F. (Eds). 2nd International Symposium on Information Theory (1973), Akadémiai Kiadó, Budapest 267-281
24. Scupola A., Ventura L., Tiberti A.C., D'Andrea D., and Balestrazzi E. Histological findings of a surgically excised myopic choroidal neovascular membrane after photodynamic therapy. A case report. Graefes Arch Clin Exp Ophthalmol 242 (2004) 605-610
25. Grossniklaus H.E., and Green W.R. Choroidal neovascularization. Am J Ophthalmol 137 (2004) 496-503
26. Verteporfin in Photodynamic Therapy Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial-VIP Report No. 1. Ophthalmology 108 (2001) 841-852
27. Gupta O.P., Boynton J.R., Sabini P., Markowitch Jr. W., and Quatela V.C. Proptosis after retrobulbar corticosteroid injections. Ophthalmology 110 (2003) 443-447
28. Dal Canto A.J., Downs-Kelly E., and Perry J.D. Ptosis and orbital fat prolapse after posterior sub-Tenon's capsule triamcinolone injection. Ophthalmology 112 (2005) 1092-1097
29. Iwao K., Inatani M., Kawaji T., Koga T., Mawatari Y., and Tanihara H. Frequency and risk factors for intraocular pressure elevation after posterior sub-Tenon capsule triamcinolone acetonide injection. J Glaucoma 16 (2007) 251-256
30. Fung A.E., Rosenfeld P.J., and Reichel E. The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide. Br J Ophthalmol 90 (2006) 1344-1349
31. Shima C., Sakaguchi H., Gomi F., et al. Complications in patients after intravitreal injection of bevacizumab. Acta Ophthalmol 86 (2008) 372-376
32. Sayanagi K., Ikuno Y., Soga K., Wakabayashi T., and Tano Y. Marginal crack after intravitreal bevacizumab for myopic choroidal neovascularization. Acta Ophthalmol 87 (2009) 460-463